Literature DB >> 12472673

IL-18 production in human pulmonary and pleural tuberculosis.

C-H Song1, J-S Lee, H-H Nam, J-M Kim, J-W Suhr, S-S Jung, M-J Na, T-H Paik, H-J Kim, J-K Park, E-K Jo.   

Abstract

Interleukin-18 (IL-18) has multiple important pro-inflammatory effects, including the induction of interferon-gamma (IFN-gamma) in various diseases. In this study, we investigated the IL-18-producing activities in human pulmonary and pleural tuberculosis (TB) in response to purified protein derivative (PPD) antigen (Ag) from Mycobacterium tuberculosis. The most significant IL-18 production was found in chronic refractory TB (CRTB) patients. However, IFN-gamma production in CRTB patients was significantly less than that in healthy tuberculin reactors or in patients with tuberculous pleurisy (TBP). Elevated levels of both IL-18 and IFN-gamma were found in pleural fluids from TBP patients. In vitro production of IL-18 was dramatically decreased following an 18 h stimulation with PPD. However, IFN-gamma was markedly increased in pleural mononuclear cells from TBP patients after in vitro stimulation with PPD. The mesothelial cell type was the main source of pro-IL-18 in pleural cells from TBP patients, suggesting an important role for these cells in TBP. Taken together, these data indicate that IL-18 is elevated in peripheral blood mononuclear cells from CRTB patients, as well as at the site of TBP, indicating a possible role for IL-18 in both protective immunity and pathologic responses in human TB.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12472673     DOI: 10.1046/j.1365-3083.2002.01143.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  7 in total

1.  IL-18 receptor expression on epithelial cells is upregulated by TNF alpha.

Authors:  Eliska Krásná; Libor Kolesár; Antonij Slavcev; Sárka Valhová; Bohumíra Kronosová; Marcela Jaresová; Ilja Stríz
Journal:  Inflammation       Date:  2005-02       Impact factor: 4.092

2.  Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.

Authors:  Y Luo; H Yamada; X Chen; A A Ryan; D P Evanoff; J A Triccas; M A O'Donnell
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

3.  Mycobacterium tuberculosis-induced gamma interferon production by natural killer cells requires cross talk with antigen-presenting cells involving Toll-like receptors 2 and 4 and the mannose receptor in tuberculous pleurisy.

Authors:  Pablo Schierloh; Noemí Yokobori; Mercedes Alemán; Verónica Landoni; Laura Geffner; Rosa M Musella; Jorge Castagnino; Matias Baldini; Eduardo Abbate; Silvia S de la Barrera; María C Sasiain
Journal:  Infect Immun       Date:  2007-08-20       Impact factor: 3.441

Review 4.  Unmet needs in respiratory diseases : "You can't know where you are going until you know where you have been"--Anonymous.

Authors:  Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

5.  Interleukin-18 and interferon-γ single nucleotide polymorphisms in Egyptian patients with tuberculosis.

Authors:  Noha A Hassuna; Mohamed El Feky; Aliae A R Mohamed Hussein; Manal A Mahmoud; Naglaa K Idriss; Sayed F Abdelwahab; Maggie A Ibrahim
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

6.  Dendritic Cell Activity Driven by Recombinant Mycobacterium bovis BCG Producing Human IL-18, in Healthy BCG Vaccinated Adults.

Authors:  Piotr Szpakowski; Franck Biet; Camille Locht; Małgorzata Paszkiewicz; Wiesława Rudnicka; Magdalena Druszczyńska; Fabrice Allain; Marek Fol; Joël Pestel; Magdalena Kowalewicz-Kulbat
Journal:  J Immunol Res       Date:  2015-08-03       Impact factor: 4.818

7.  Evaluation of polymerase chain reaction for diagnosis of "tuberculous pleurisy".

Authors:  Amir M H Asnaashari; Mohammad Towhidi; Reza Farid; Mohammad R Abbaszadegan; Davood Attaran; Seiedeh Sedigheh Fatemi; Atefeh Amiri Darban
Journal:  Tanaffos       Date:  2011
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.